You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Virological breakthrough after immune checkpoint inhibitor and nucleos(t)ide analog treatment in patients with hepatitis B surface antigen positive hepatocellular carcinoma: a real-world study

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Virological breakthrough after immune checkpoint inhibitor and nucleos(t)ide analog treatment in patients with hepatitis B surface antigen positive hepatocellular carcinoma: a real-world study

 

Online download statistics by month:

Online download statistics by month: November 2021 to July 2025

AbstractFullPdf
Nov 202127527579
Dec 202114114141
Jan 2022484913
Feb 2022282817
Mar 2022394420
Apr 2022363712
May 2022777817
Jun 202291967
Jul 202245453
Aug 2022656613
Sep 2022808823
Oct 2022696921
Nov 202228288
Dec 202228288
Jan 2023212317
Feb 2023444812
Mar 202323258
Apr 202315159
May 2023242413
Jun 202328287
Jul 2023313114
Aug 202336365
Sep 202336364
Oct 202315153
Nov 202331337
Dec 2023373711
Jan 202424257
Feb 202414147
Mar 2024333334
Apr 202432329
May 2024161610
Jun 202427263
Jul 202430316
Aug 2024292896
Sep 202426266
Oct 2024252512
Nov 202421229
Dec 202425267
Jan 202519195
Feb 202530309
Mar 2025171811
Apr 2025424214
May 2025171710
Jun 202522247
Jul 2025110
Total18411878654